Elisabetta Leo

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Radiation Therapy

Dna Damage Response

Prostate Cancer

Top Venues

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Giulia Dellavedova, Alessandra Decio, Laura Formenti, Mark R Albertella, Joanne Wilson, Anna D Staniszewska, Elisabetta Leo, Raffaella Giavazzi, Carmen Ghilardi, Maria Rosa Bani
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin. Cancer research communications 3 (3) (2023)
Giulia Dellavedova, Alessandra Decio, Laura Formenti, Mark R Albertella, Joanne Wilson, Anna D Staniszewska, Elisabetta Leo, Raffaella Giavazzi, Carmen Ghilardi, Maria Rosa Bani
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin. Cancer research communications 3 (3) (2023)
Anna D Staniszewska, Domenic Pilger, Sonja J Gill, Kunzah Jamal, Natacha Bohin, Sofia Guzzetti, Jacob A Gordon, Gregory Hamm, Gill Mundin, Giuditta Illuzzi, Andy Pike, Lisa McWilliams, Gareth A Maglennon, Jonathan Rose, Glen Hawthorne, Miguel A Cortés González, Christer Halldin, Peter Johnström, Magnus Schou, Susan E Critchlow, Stephen E Fawell, Jeffrey W Johannes, Elisabetta Leo, Barry R Davies, Sabina Cosulich, Jann N Sarkaria, Lenka Oplustil O'Connor, Petra Hamerlik
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kunzah Jamal, Alessandro Galbiati, Joshua Armenia, Giuditta Illuzzi, James A Hall, Sabrina Bentouati, Daniel Barrell, Miika Ahdesmäki, null null, Lenka Oplustil O'Connor, Elisabetta Leo, Josep V Forment
Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition. Cancer research communications 2 (10) (2022)
Krista Kinneer, Philipp Wortmann, Zachary A Cooper, Niall J Dickinson, Luke A Masterson, Thais Cailleau, Ian Hutchinson, Balakumar Vijayakrishnan, Mary McFarlane, Kathryn Ball, Michael Davies, Arthur Lewis, Yue Huang, Anton I Rosenbaum, Jiaqi Yuan, Jon Chesebrough, Judith Anderton, Noel Monks, Steven J Novick, Jixin Wang, Nazzareno Dimasi, R James Christie, Darrin Sabol, Frances Anne Tosto, Yann Wallez, Elisabetta Leo, Mark R Albertella, Anna D Staniszewska, David A Tice, Philip W Howard, Nadia Luheshi, Puja Sapra
Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Giuditta Illuzzi, Anna D Staniszewska, Sonja J Gill, Andy Pike, Lisa McWilliams, Susan E Critchlow, Anna Cronin, Stephen E Fawell, Glen Hawthorne, Kunzah Jamal, Jeffrey W Johannes, Emilyanne Leonard, Ruth Macdonald, Gareth A Maglennon, Jenni Nikkilä, Lenka Oplustil O'Connor, Aaron Smith, Harriet Southgate, Joanne Wilson, James W T Yates, Sabina Cosulich, Elisabetta Leo
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Kunzah Jamal, Alessandro Galbiati, Joshua Armenia, Giuditta Illuzzi, James A Hall, Sabrina Bentouati, Daniel Barrell, Miika Ahdesmäki, null null, Lenka Oplustil O'Connor, Elisabetta Leo, Josep V Forment
Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition. Cancer research communications 2 (10) (2022)
Sophie E Willis, Claudia Winkler, Martine P Roudier, Tarrion Baird, Paola Marco-Casanova, Emma V Jones, Philip Rowe, Jaime Rodriguez-Canales, Helen K Angell, Felicia S L Ng, Paul M Waring, Darren Hodgson, Jonathan A Ledermann, Johanne I Weberpals, Emma Dean, Elizabeth A Harrington, J Carl Barrett, Andrew J Pierce, Elisabetta Leo, Gemma N Jones
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response. British journal of cancer 125 (12) (2021)
Claudia Winkler, Joshua Armenia, Gemma N Jones, Luis Tobalina, Matthew J Sale, Tudor Petreus, Tarrion Baird, Violeta Serra, Anderson T Wang, Alan Lau, Mathew J Garnett, Patricia Jaaks, Elizabeth A Coker, Andrew J Pierce, Mark J O'Connor, Elisabetta Leo
SLFN11 informs on standard of care and novel treatments in a wide range of cancer models. British journal of cancer 124 (5) (2020)